Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Response to Standard PBC Treatment at 1 Year Linked to Lower Long-Term Risks

(MedPage Today) -- A biochemical response to ursodeoxycholic acid (UDCA) at 12 months was associated with lower 5-year risks of hepatic decompensation and mortality in patients with primary biliary cholangitis (PBC), a propensity-matched landmark...

Response to Standard PBC Treatment at 1 Year Linked to Lower Long-Term Risks

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 12 November →